Skip to content
Subscriber Only

Color Genomics Raises $45 Million to Expand Genetic Testing

  • Startup offers test for $50 to family of those with mutation
  • General Catalyst leads round, brings total funding to $60M

Color Genomics Inc., the three-year-old startup aiming to democratize genetic testing, sealed $45 million in funding as it seeks to make its tests for cancer more affordable and accessible, the company announced Tuesday.

General Catalyst Partners, a backer of Snap Inc. and Stripe Inc., led the round of capital that Color will use to further develop its tests and expand its software capabilities. For $249, Color analyzes 30 genes to help people understand their risk for hereditary cancers, such as breast, colon and pancreatic cancer. The company said it will begin offering the test for $50 to first-degree relatives of those identified with a hereditary cancer mutation.